Main Article Content


The biggest Challenge moon-faced by today’s chemist and formulation mortal is ocular drug delivery. The route of drug administration and particularly for the treatment of anterior phase diseases the topical eye drop is that the most convenient and patient compliant. By numerousprecorneal, dynamic and static ocular barriers, the delivery of medication to the targeted ocular tissues is restricted. In target tissues therapeutic drug levels aren't maintained for extended period. Within the past twenty years, ocular drug delivery analysis acceleratedly advanced towards developing a completely unique, safe and patient compliant formulation and drug delivery devices/techniques, which can surpass these barriers and maintain drug levels in tissues. By modulation of typical topical solutions with permeation and viciousness enhancers, anterior phase drug delivery advances


Accommodation Myopia Hypermetropia Presbyopia Cataract Vascular System

Article Details